|1.||Tanaka, Hiroyasu: 2 articles (01/2006 - 04/2003)|
|2.||Katayama, Seiji: 1 article (01/2006)|
|3.||Nagata, Ryu: 1 article (01/2006)|
|4.||Ohtani, Ken-Ichi: 1 article (01/2006)|
|5.||Shimago, Kozo: 1 article (01/2006)|
|6.||Ohtani, Ken-ichi: 1 article (04/2003)|
|7.||Ohno, Yukihiro: 1 article (04/2003)|
04/01/2003 - "These studies revealed that SM-31900 can exert a neuroprotective effect when it is administered up to at least 60min after the onset of ischemia in the MCAo model, an animal model of stroke, indicating that SM-31900 is a good candidate for treating acute brain ischemia."
01/01/2006 - "In fact, SM-18400 and SM-31900 exhibited efficacy in several animal stroke models using intravenous infusion protocols. "
|3.||Brain Ischemia (Cerebral Ischemia)
|4.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
|1.||Glycine Receptors (Glycine Receptor)